Getein Biotech, Inc (SHA:603387)
China
· Delayed Price · Currency is CNY 8.04
+0.04 (0.50%)
Apr 24, 2025, 2:45 PM CST
Getein Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 23, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 4,078 | 5,579 | 6,339 | 7,254 | 8,911 | 6,002 | Upgrade
|
| Market Cap Growth | -21.05% | -12.00% | -12.61% | -18.60% | 48.48% | 21.44% | Upgrade
|
| Enterprise Value | 3,789 | 5,572 | 5,454 | 6,496 | 8,162 | 5,194 | Upgrade
|
| Last Close Price | 8.04 | 10.73 | 11.82 | 13.31 | 16.04 | 10.66 | Upgrade
|
| PE Ratio | 16.09 | 19.94 | 12.71 | 18.18 | 29.24 | 17.67 | Upgrade
|
| Forward PE | - | 17.43 | 17.43 | 17.43 | 17.55 | 10.50 | Upgrade
|
| PS Ratio | 3.27 | 4.08 | 3.48 | 5.18 | 7.93 | 6.20 | Upgrade
|
| PB Ratio | 1.47 | 2.04 | 2.38 | 3.19 | 4.45 | 3.57 | Upgrade
|
| P/TBV Ratio | 1.68 | 2.31 | 2.70 | 3.62 | 5.10 | 3.78 | Upgrade
|
| P/FCF Ratio | 14.30 | 74.29 | 23.88 | 28.70 | 123.88 | 59.47 | Upgrade
|
| P/OCF Ratio | 9.34 | 16.74 | 13.13 | 16.78 | 48.05 | 26.59 | Upgrade
|
| PEG Ratio | - | 1.34 | 1.34 | 1.34 | - | - | Upgrade
|
| EV/Sales Ratio | 3.04 | 4.07 | 2.99 | 4.64 | 7.27 | 5.37 | Upgrade
|
| EV/EBITDA Ratio | 11.34 | 18.80 | 9.71 | 14.21 | 23.77 | 13.99 | Upgrade
|
| EV/EBIT Ratio | 16.62 | 26.25 | 10.97 | 15.86 | 26.55 | 15.13 | Upgrade
|
| EV/FCF Ratio | 13.29 | 74.20 | 20.54 | 25.70 | 113.47 | 51.47 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.24 | 0.22 | 0.22 | 0.19 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 2.14 | 2.19 | 1.04 | 1.08 | 1.12 | 0.26 | Upgrade
|
| Debt / FCF Ratio | 2.50 | 8.88 | 2.23 | 1.96 | 5.35 | 0.94 | Upgrade
|
| Asset Turnover | 0.32 | 0.37 | 0.54 | 0.48 | 0.48 | 0.54 | Upgrade
|
| Inventory Turnover | 1.60 | 1.87 | 2.58 | 2.09 | 2.22 | 1.85 | Upgrade
|
| Quick Ratio | 1.50 | 1.56 | 1.77 | 2.54 | 2.86 | 4.37 | Upgrade
|
| Current Ratio | 1.90 | 2.20 | 2.50 | 2.91 | 3.22 | 4.95 | Upgrade
|
| Return on Equity (ROE) | 9.52% | 10.51% | 20.41% | 19.26% | 17.92% | 22.84% | Upgrade
|
| Return on Assets (ROA) | 3.70% | 3.56% | 9.11% | 8.77% | 8.16% | 11.99% | Upgrade
|
| Return on Capital (ROIC) | 4.11% | 3.98% | 10.31% | 9.92% | 9.23% | 13.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.00% | 7.60% | 18.30% | 17.60% | 15.00% | 20.30% | Upgrade
|
| Earnings Yield | 6.20% | 5.01% | 7.87% | 5.50% | 3.42% | 5.66% | Upgrade
|
| FCF Yield | 6.99% | 1.35% | 4.19% | 3.48% | 0.81% | 1.68% | Upgrade
|
| Dividend Yield | 2.25% | 1.86% | 2.88% | 1.82% | 1.15% | 1.91% | Upgrade
|
| Payout Ratio | 43.53% | 78.42% | 28.21% | 25.96% | 38.01% | 22.92% | Upgrade
|
| Buyback Yield / Dilution | 0.29% | 0.08% | 0.48% | -0.72% | 0.82% | -0.48% | Upgrade
|
| Total Shareholder Return | 2.54% | 1.95% | 3.35% | 1.11% | 1.97% | 1.43% | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.